Targeting of adenovirus to human renal cell carcinoma cells

Urology

Volumn 62, Issue 3, 2003, Pages 559-565

  Jongmans, Wim ^b   Van Den Oudenalder, Kelly ^b   Tiemessen, Dorien M ^b   Molkenboer, Janneke ^b   Willemsen, Ralph ^b   Mulders, Peter F A ^b   Oosterwijk, Egbert ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CARBONIC ANHYDRASE 9 PROTEIN; GREEN FLUORESCENT PROTEIN; LYASE; RECOMBINANT ANTIBODY; RECOMBINANT BISPECIFIC SINGLE CHAIN ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CANCER GENE THERAPY; COMPARATIVE STUDY; CONTROLLED STUDY; COXSACKIEVIRUS VECTOR; EXPRESSION VECTOR; FLOW CYTOMETRY; GENE CONSTRUCT; GENE TARGETING; GENETIC SUSCEPTIBILITY; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; KIDNEY CARCINOMA; KIDNEY METASTASIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN EXPRESSION; VIRAL GENE THERAPY; VIRUS RECOMBINANT;

EID: 0041733307     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0090-4295(03)00378-9     Document Type: Article

References (28)

1. Sokoloff M.H., deKernion J.B., Figlin R.A., et al. Current management of renal cell carcinoma. CA Cancer J Clin. 46:1996;284-302.
2. Mulders P., Figlin R., deKernion J.B., et al. Renal cell carcinoma recent progress and future directions . Cancer Res. 57:1997;5189-5195.
3. Vogelzang N.J., Lipton A., Figlin R.A. Subcutaneous interleukin-2 plus interferon-α2a in metastatic renal cell carcinoma an outpatient multicenter trial . J Clin Oncol. 11:1993;1809-1816.
4. Mulders P., Tso C.L., Gitlitz B., et al. Presentation of renal tumor antigens by human dendritic cells activates tumor-infiltrating lymphocytes against autologous tumor implications for live kidney cancer vaccines . Clin Cancer Res. 5:1999;445-454.
5. Bergelson J.M., Cunningham J.A., Droguett G., et al. Iso-lation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5. Science. 275:1997;1320-1323.
6. Wickham T.J., Mathias P., Cheresh D.A., et al. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment. Cell. 73:1993;309-319.
7. Watkins S.J., Mesyanzhinov V.V., Kurochkina L.P., et al. The 'adenobody' approach to viral targeting specific and enhanced adenoviral gene delivery . Gene Ther. 4:1997;1004-1012.
8. Haisma H.J., Grill J., Curiel D.T., et al. Targeting of adenoviral vectors through a bispecific single-chain antibody. Cancer Gene Ther. 7:2000;901-904.
9. Nettelbeck D.M., Miller D.W., Jerome V., et al. Targeting of adenovirus to endothelial cells by a bispecific single-chain diabody directed against the adenovirus fiber knob domain and human endoglin (CD105). Mol Ther. 3:2001;882-891.
10. Van Beusechem V.W., Grill J., Mastenbroek D.C., et al. Efficient and selective gene transfer into primary human brain tumors by using single-chain antibody-targeted adenoviral vectors with native tropism abolished. J Virol. 76:2002;2753-2762.
11. Oosterwijk E., Bander N.H., Divgi C.R., et al. Antibody localization in human renal cell carcinoma a phase I study of monoclonal antibody G250 . J Clin Oncol. 11:1993;738-750.
12. Divgi C.R., Bander N.H., Scott A.M., et al. Phase I/II radioimmunotherapy trial with iodine-131-labeled monoclonal antibody G250 in metastatic renal cell carcinoma. Clin Cancer Res. 4:1998;2729-2739.
13. Steffens M.G., Oosterwijk E., Zegwaart Hagemeier N.E., et al. Immunohistochemical analysis of intratumoral heterogeneity of [131I]cG250 antibody uptake in primary renal cell carcinomas. Br J Cancer. 78:1998;1208-1213.
14. 131I-labeled chimeric monoclonal antibody G250. Clin Cancer Res. 5:1999;3268s-3274s.
15. Fallaux F.J., Kranenburg O., Cramer S.J., et al. Characterization of 911 a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors . Hum Gene Ther. 7:1996;215-222.
16. Shayakhmetov D.M., Papayannopoulou T., Stamatoyannapoulos G., et al. Efficient gene transfer into human CD34+ cells by a retargeted adenovirus vector. J Virol. 74:2000;2567-2583.
17. He T.-G., Zhou S., Da Costa L.T., et al. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 95:1998;2509-2514.
18. Grabmaier K., Vissers J.L.M., De Weijert M.C.A., et al. Molecular cloning and immunogenicity of renal cell carcinoma-associated antigen G250. Int J Cancer. 85:2000;865-870.
19. Weijtens M.E., Willemsen R.A., Hart E.H., et al. A retroviral vector system 'STITCH' in combination with an optimized single chain antibody chimeric receptor gene structure allows efficient gene transduction and expression in human T lymphocytes. Gene Ther. 5:1998;1195-1203.
20. Willemsen R.A., Weijtens M.E., Ronteltap C., et al. Grafting primary human T lymphocytes with cancer-specific chimeric single chain and two chain TCR. Gene Ther. 7:2000;1369-1377.
21. Uemura H., Beniers A.J., Okajima E., et al. Vaccination with anti-idiotype antibodies mimicking a renal cell carcinoma-associated antigen induces tumor immunity. Int J Cancer. 58:1994;555-561.
22. Rea D., Havenga M.J., van Den Assem M., et al. Highly efficient transduction of human monocyte-derived dendritic cells with subgroup B fiber-modified adenovirus vectors enhances transgene-encoded antigen presentation to cytotoxic T cells. J Immunol. 166:2001;5236-5244.
23. Rea D., Schagen F.H., Hoeben R.C., et al. Adenoviruses activate human dendritic cells without polarization toward a T-helper type 1-inducing subset. J Virol. 73:1999;10245-10253.
24. Dürrbach A., Angevin E., Poncet P., et al. Antibody-mediated endocytosis of G250 tumor-associated antigen allows targeted gene transfer to human renal cell carcinoma in vitro. Cancer Gene Ther. 6:1999;564-571.
25. Krasnykh V., Dmitriev I., Mikheeva G., et al. Characterization of an adenovirus vector containing a heterologous peptide epitope in the HI loop of the fiber knob. J Virol. 72:1998;1844-1852.
26. Wickham T.J., Tzeng E., Shears L.L., et al. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins. J Virol. 71:1997;8221-8229.
27. Van Beusechem V.W., van Rijswijk A.L., van Es H.H., et al. Recombinant adenovirus vectors with knobless fibers for targeted gene transfer. Gene Ther. 7:2000;1940-1946.
28. Krasnykh V., Belousova N., Korokhov N., et al. Genetic targeting of an adenovirus vector via replacement of the fiber protein with the phage T4 fibritin. J Virol. 75:2001;4176-4183.